Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
07/2005
07/26/2005US6921824 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents
07/26/2005US6921821 Antagonists of melanin concentrating hormone receptor
07/26/2005US6921771 Administering a fused aminoquinoline derivative such as (5R)-5-(methylamino)-5,6-dihydro-4H-imidazo(4,5,1-ij) quinoline-2(1H)-thione or pharmaceutically acceptable salts
07/26/2005US6921763 Protein kinase inhibitors
07/26/2005US6921761 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
07/26/2005US6921644 Nucleotie sequences coding polypeptide for use in the treatment of reproductive disorders
07/26/2005CA2470200C Pharmaceutical composition
07/26/2005CA2152902C Selective ligands of receptors 5-ht1d-5ht1b derived from indole-piperazine useful as medicaments
07/21/2005WO2005065700A1 Life-prolonging agent comprising polished rice-origin components as the active ingredient
07/21/2005US20050159474 Chemical compounds
07/21/2005US20050159463 5-methoxy-3-(2-(2-furamido) ethyl)indole; related to melatonin, but pharmacologicaly and pharmacokineticy different; longer duration, selective localization and greater efficacy
07/21/2005US20050159421 Ethylene diamine derivatives and their use as orexin-receptor antagonists
07/21/2005US20050159405 Substituted 10-aryl-11h-benzo[b]fluourenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors
07/21/2005US20050159337 Use of botulinum toxin therapy for treatment of overactive bladder
07/21/2005US20050159335 Pharmaceutical administration form for peptides, process for its preparation, and use
07/21/2005US20050158719 Polypeptide serving as angiogenic marker and dna thereof
07/20/2005EP1555029A1 Use of substances having oxytocin antagonistic properties for the preparation of a medicament for treating hypertension
07/20/2005EP1554286A1 Fused heterocyclic isoxazoline derivatives and their use as anti-depressants
07/20/2005EP1554283A1 5-substituted 7,9-difluoro-5 i h /i -chromeno (3,4-f) quinoline compounds as selective progesterone receptor modulators
07/20/2005EP1554245A1 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase
07/20/2005EP1554016A2 In vitro synchronisation of nuclear and cytoplasmatic maturation of oocytes involving addition and removal of phosphodiesterase type 3 inhibitor
07/20/2005EP1553973A2 eNOS MUTANTS USEFUL FOR GENE THERAPY
07/20/2005EP1553972A1 Method of treating chronic pelvic pain syndrome by administration of chrorionic gonadotropin
07/20/2005EP1553912A1 Compositions and methods for the diagnosis and treatment of tumor
07/20/2005EP1401467A4 Alpha-fetoprotein peptides and uses thereof
07/20/2005EP1317309B1 Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant
07/20/2005EP1284959B1 Compounds for modulating the rage receptor
07/20/2005EP1268396B1 Diphenyl ether compounds useful in therapy
07/20/2005EP1261328B1 Il-8 receptor antagonists
07/20/2005EP1244672B1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
07/20/2005EP1229965B1 Placental human neurokinin b precursor
07/20/2005EP1198570B1 Monomeric protein of the tgf-beta family
07/20/2005EP1189583B1 Indole derivatives
07/20/2005EP1005538B1 Potassium channel proteins for use in gene therapy for alleviating erectile dysfunction
07/20/2005EP0910571B1 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis
07/20/2005EP0789761B1 Human scf, a splice variant thereof, its pharmaceutical use
07/20/2005CN1643138A Novel cytokine ZCYTOR17 ligand
07/20/2005CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
07/20/2005CN1642939A Pyridinoylpiperidines as 5-HTLF agonists
07/20/2005CN1642938A New compounds
07/20/2005CN1642918A Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine
07/20/2005CN1642917A Non-peptide GnRH antagonists
07/20/2005CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
07/20/2005CN1642910A Synthesis of indole thiazole compounds as ligands for the AH receptor
07/20/2005CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase
07/20/2005CN1642904A Salts of nateglinide
07/20/2005CN1642577A Preparation comprising buprenorphine
07/20/2005CN1642559A Combination comprising an HMG-CoA reductase inhibitor and an insulin secretor enhancer or an insulin sensitizer
07/20/2005CN1642551A Inhibitors of histone deacetylase
07/20/2005CN1642542A Angiogenesis inhibitors
07/20/2005CN1642540A Suramin and derivatives thereof as topical microbicide and contraceptive
07/20/2005CN1640891A Epinephelus anti-transgenosis protein and nucleotide sequence and use thereof
07/20/2005CN1640472A Chinesle herbal medicine liquor
07/20/2005CN1640456A Chinese medicine for treating chronic pelvic inflammation and its preparing process
07/20/2005CN1640445A Fresh eucommia leaf preparation and its preparing method
07/20/2005CN1640442A Fresh multiflower knotweed tuber preparation and its preparing method
07/20/2005CN1640438A Medicine for preventing and treating nipple chap and its preparing method
07/20/2005CN1640436A Chinese medicine composition for treating menstrual period syndrome
07/20/2005CN1640426A Biological energy reinforced agent-sheep kidney concentrated liquor
07/20/2005CN1640394A Andrographolide sulfonic acid sodium lyophilized powder for injection and its preparing method
07/20/2005CN1640390A Novel sodium houttuynin lyophilized powder for injection and its preparing method
07/20/2005CN1640389A Medicine for treating bacterial vaginitis and its preparing method
07/20/2005CN1211401C Human leukocyte interleukin-17 receptor sample protein, and coding gene and use thereof
07/20/2005CN1211374C Heterocyclic derivative, its preparation method and medicine compositioncontaining them
07/20/2005CN1211120C Injection for treating hydrocele of testis
07/20/2005CN1211087C Competitive progesterone antagnoists for regulating female fertility as required
07/19/2005US6919362 For use as hypoglycaemic and hypolipidaemic agents
07/19/2005US6919357 Human sexual disorders; therapy for impotency
07/19/2005US6919345 Sulfonate substituted pyrazol pyridine derivatives
07/19/2005US6919332 Enzyme inhibitors such as 5-(2-Methoxy-ethyl)-5-(4-(1-pyridin -3-yl-1H-indazol-5-yloxy)-phenoxy)-pyrimidine-2,4,6-trione, used as antiinflammatory and anticarcinogenic agents
07/14/2005WO2005063725A1 Phenylpropanoic acid derivatives
07/14/2005WO2005063241A1 Preventive and/or therapeutic agent for disease in which mitochondrial benzodiazepine receptor participates
07/14/2005WO2005009480A3 Implants containing codrugs
07/14/2005WO2003059294A3 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
07/14/2005WO2003029424A3 Novel proteins and nucleic acids encoding same
07/14/2005US20050155089 Transport protein for use in identifying modulators for prevention and treatment of inflammation, cardiovascular, neurological, reproductive and developmental disorders
07/14/2005US20050154232 Nitrosation of the diphenylamine with an alkali metal nitrite in an acidic medium; the nitrosodiphenylamines increase the bioavailability of endothelial nitrogen monoxide; the diphenylamines are used as antioxidants and free radical scavengers; insulin resistance
07/14/2005US20050154049 Administering an ultrasonic contrast agent; imaging tissue; medical diagnosis
07/14/2005US20050154039 5-Sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
07/14/2005US20050154028 1-(3-Fluoro-phenyl)-3-[4-methoxy-3-(2-piperidin-1-yl-ethoxy)-phenyl]-imidazolidin-2-one; serotonin 5-ht2c receptor antagonist; antidepressant and anxiolytic agent
07/14/2005US20050154025 6-[4-(fluoro- or trifluoromethyl)pyridyl-4-(p-fluorophenyl)-5-methylimidazol-2-yl] pyridones; cyclization of 1-phenyl-1-pyridyl-1,2-diaminopropanes with an acid, amidine, or nitrile compound; neuropeptide Y receptor antagonists; cardiovascular and central nervous system disorders, metabolic diseases
07/14/2005US20050153987 Compounds
07/14/2005US20050153980 Substituted indoles
07/14/2005US20050153974 Heterocyclymethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors
07/14/2005US20050153960 Substituted arylamine derivatives and methods of use
07/14/2005US20050153957 Beta2-adrenoceptor agonists
07/14/2005US20050153949 Testosterone derivative
07/14/2005US20050153917 Gene overexpression/underexpression; antibodies; drug screening; kits
07/14/2005US20050153902 Inhibitors of integrin avb6
07/14/2005US20050153889 Modulation of pericyte proliferation
07/14/2005US20050153888 oligopeptides capable of stimulating the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM), used for treatment of normal, degenerated and damaged NCAM presenting cells
07/14/2005US20050153878 Fgfr agonists
07/14/2005US20050152926 For immunization and/or diagnosis; eg pneumonia, cardiovascular diseases, atherosclerosis, bronchitis
07/13/2005EP1553074A1 Fused benzene derivative and use
07/13/2005EP1551973A1 New gdf-9 and gdf-9b (bmp-15) sequences for altering mammalian ovarian function and ovulation rate
07/13/2005EP1551841A1 Pyrazolopyrimidines as kinase inhibitors
07/13/2005EP1551837A1 Phosphodiesterase 4 inhibitors
07/13/2005EP1551834A1 Substituted quinazolinone compounds
07/13/2005EP1551822A2 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them
07/13/2005EP1551461A2 Azo compounds for type i phototherapy